Author Archive

FDA Approves Guardian™ Connect CGM System

I am excited to announce that the Food and Drug Administration (FDA) has approved our Guardian™ Connect continuous glucose monitoring (CGM) system for use in the United States. To hear more about this important milestone, watch my video message. The Guardian™ Connect system is the first smart standalone CGM system to help people with

Diabeter Wins Value-Based Healthcare Prize 2017

On May 11, 2017, the Value-Based Healthcare Center Europe awarded Diabeter with the Value-Based Healthcare Prize 2017. I am so proud of the work by the Diabeter team, and am not surprised that their hard work and innovative approach is being recognized. The Value-Based Healthcare Prize rewards projects that have adopted a fundamentally new

Growing the Diabeter Model

Part 3 of a three-part series about Medtronic and Diabeter. In part 1, we discussed our acquisition of Diabeter as part of our overall value-based healthcare strategy. In part 2, we highlighted the components of a value-based healthcare system and how Diabeter exemplifies them. In part 3, we discuss what’s next for Medtronic and

Moving to a High-Value Healthcare Delivery System

Part 2 of a three-part series about Medtronic and Diabeter. In part 1, we discussed our acquisition of Diabeter as part of our overall value-based health care strategy. In part 2, we highlight the components of a value-based healthcare system and how Diabeter exemplifies them. In a value-based healthcare system, the overarching goal for

Transforming Diabetes Care into Value-Based Care Delivery

Part 1 of a three-part series about Medtronic and Diabeter, which Medtronic acquired in April 2015 as part of our vision to transform diabetes care so patients have greater freedom and better health. Diabetes represents one of the biggest challenges to the healthcare system given its exponential growth, the cost to manage the disease

Medtronic Turning Point Program: Helping Healthcare Systems Manage At-Risk Diabetes Patients

The estimated medical costs of managing people diagnosed with diabetes in the United States is $176 billion and community hospitals carry more than 40% of that financial burden.[1] People with diabetes – particularly those with lower socioeconomic status or limited access to primary care – frequently seek care in hospital emergency departments (ED).[2],[3] When

Providing Easier and Better Access to Pump and CGM Data on Smartphones with MiniMed Connect

For people with diabetes, constantly monitoring blood sugar levels can be cumbersome and anything but discreet. That’s why we created the MiniMed Connect mobile application, originally available on iOS. Now we are introducing MiniMed Connect for the Android™ operating system –the first and only product that enables people with diabetes to discreetly see real-time

Expanding Diabetes Care Services with Canary Health

A Growing Epidemic More than 29 million people in the United States (US) live with diabetes, and an additional 86 million people are at risk for developing the disease.[i] Each year, pre-diabetes and diabetes costs $322 billion in the US.[i] It is clear we need an innovative and comprehensive approach to diabetes prevention and

First Live Experience of Sugar.IQ with Watson for People with Diabetes

I am excited to announce that Sugar.IQ with Watson, the first-of-its-kind cognitive app that helps detect important patterns and trends for people with diabetes, is now in live use for the first time. With app development now completed, we will conduct real-world testing of the final release candidate application with up to 100 MiniMed

Addressing the Highs and Lows of Diabetes with IBM Watson

As you know, we are collaborating with IBM Watson to develop solutions that will help people with diabetes better manage the disease. Recently, IBM Watson began running a television advertisement citing Medtronic as an example of the work they’re doing in healthcare. This is a testament to the strength of our partnership and rapid